Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics
about
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorderAdvances in molecular genetic studies of attention deficit hyperactivity disorder in ChinaCOMT val158met moderation of dopaminergic drug effects on cognitive function: a critical reviewCOMT Val158Met Polymorphism Modulates Cognitive Effects of Dietary Intervention.The ethics of elective psychopharmacologyPharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.Imaging genomics and response to treatment with antipsychotics in schizophrenia.COMT and prenatal maternal smoking in associations with conduct problems and crime: the Pelotas 1993 birth cohort study.Catechol-O-Methyltransferase Genotypes and Parenting Influence on Long-Term Executive Functioning After Moderate to Severe Early Childhood Traumatic Brain Injury: An Exploratory Study.White matter alterations related to attention-deficit hyperactivity disorder and COMT val(158)met polymorphism: children with valine homozygote attention-deficit hyperactivity disorder have altered white matter connectivity in the right cingulum (ciRole of COMT in ADHD: a systematic meta-analysis.DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents.Cathechol-O-methyltransferase Val(158)Met polymorphism is associated with disruptive behavior disorders among children and adolescents with ADHD.Sensory gating deficit is associated with catechol-O-methyltransferase polymorphisms in bipolar disorder.
P2860
Q24652360-DA749E29-99B2-4714-A696-874B504CDEA9Q26995422-50C96531-2811-4536-8847-685F2FFACA8BQ28074860-2BA9DA6E-A9E5-4247-828C-4EB2B4F216D3Q34343510-F47915DC-1776-44FF-AA50-83AAE47CD417Q35886546-8534D6AC-724B-47EA-818A-EC2990110C1BQ36401912-AEDD25B3-B456-4367-8A50-0261AA51D0D0Q36401916-170FBE14-EEF1-4B6D-9E6F-B43E0C5C93DCQ37101449-E73EFDED-45AC-4B07-B8F6-07F5B9823396Q40392781-F20D0DB7-8E29-4986-B68F-54546307C7E5Q40608072-9BBE8640-6E9E-495E-90C2-2BE5BC8A0602Q46162576-E661B947-A24D-41A3-B318-D493184E1505Q46693337-6F7E8AAB-6851-45EF-9AE6-4C9FBA59F6A8Q50771624-278CFFC3-ECAD-474A-BAC9-870C7C6FFB36Q51461425-8711F05C-E6C2-43EF-B452-57072F97F3B8
P2860
Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Catechol-O-methyltransferase p ...... ons for cognitive therapeutics
@ast
Catechol-O-methyltransferase p ...... ons for cognitive therapeutics
@en
Catechol-O-methyltransferase p ...... ons for cognitive therapeutics
@nl
type
label
Catechol-O-methyltransferase p ...... ons for cognitive therapeutics
@ast
Catechol-O-methyltransferase p ...... ons for cognitive therapeutics
@en
Catechol-O-methyltransferase p ...... ons for cognitive therapeutics
@nl
prefLabel
Catechol-O-methyltransferase p ...... ons for cognitive therapeutics
@ast
Catechol-O-methyltransferase p ...... ons for cognitive therapeutics
@en
Catechol-O-methyltransferase p ...... ons for cognitive therapeutics
@nl
P2860
P3181
P1433
P1476
Catechol-O-methyltransferase p ...... ons for cognitive therapeutics
@en
P2093
Catherine M Diaz-Asper
Terry E Goldberg
P2860
P304
P3181
P356
10.1016/J.NURX.2005.12.010
P407
P577
2006-01-01T00:00:00Z